Novo Nordisk in record growth due to obesity and diabetes drug sales
Danish pharmaceutical company Novo Nordisk has achieved the highest year-on-year revenue growth by sales during the second quarter of 2023 – in comparison to the other 20 top pharmaceutical firms, …
Novo Nordisk in record growth due to obesity and diabetes drug sales Read More